Michael Rudnicki

Michael Rudnicki is the founder of Fate Therapeutics, Inc. (founded in 2007).
Dr. Rudnicki is the founder of Satellos Bioscience, Inc. (founded in 2018) and holds the title of Chief Discovery Officer.
Dr. Rudnicki is also the founder of Verio Therapeutics, Inc. Dr. Rudnicki is the Director-Sprott Centre for Stem Cell Research at Ottawa Hospital Research Institute.
Dr. Rudnicki is the Scientific Director at Stem Cell Network.
Dr. Rudnicki is a Professor at the University of Ottawa.
Dr. Rudnicki was the Director at The Ontario Institute For Regenerative Medicine.
Dr. Rudnicki earned an undergraduate degree and a doctorate from the University of Ottawa.